✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
He was diagnosed as congenital afibrinogenemia, and reported for the rarity of disease, and discussion of novel therapeutic approaches
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Congenital afibrinogenemia is a rare bleeding disorder.
📊
Key Findings & Data:It may be manifested as umblical, mucosal, intramuscular, intraarticular, or life-threatening intracranial bleeding.
💡
Conclusion & Impact:He was diagnosed as congenital afibrinogenemia, and reported for the rarity of disease, and discussion of novel therapeutic approaches
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Congenital afibrinogenemia · umblical cord bleeding · fibrinogen concentrate
Abstract
Congenital afibrinogenemia is a rare bleeding disorder. It may be manifested as umblical, mucosal, intramuscular, intraarticular, or life-threatening intracranial bleeding. A third-day-old infant was admitted for umblical cord bleeding, and was found to have a prolonged prothrobin time [PT], and activated partial thromboplastin time [aPTT], and a very low fibrinogen level. He was diagnosed as congenital afibrinogenemia, and reported for the rarity of disease, and discussion of novel therapeutic approaches
🔖
Cite This Article
YİLDİRİM, A. T., BİLGİLİ, G., BUGA, O., TEKİN, O., GULEN, H. (2014). A Case Report of Congenital Afibrinogenemia. Medical Science and Discovery, Cilt: 1 Sayı: 1, 27–30. https://ajindex.com/articles/1003186